Gantzert Investment Company’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$3.56M Buy
45,001
+2,583
+6% +$202K 3.22% 11
2020
Q2
$3.13M Buy
42,418
+2,489
+6% +$187K 3.07% 13
2020
Q1
$2.93M Buy
39,929
+1,504
+4% +$118K 3.14% 12
2019
Q4
$3.33M Buy
38,425
+1,782
+5% +$146K 3.05% 12
2019
Q3
$2.94M Buy
36,643
+3,736
+11% +$299K 2.88% 12
2019
Q2
$2.63M Buy
32,907
+409
+1% +$31.3K 2.6% 13
2019
Q1
$2.58M Sell
32,498
-42
-0.1% -$3.14K 2.61% 13
2018
Q4
$2.37M Buy
+32,540
New +$2.3M 2.65% 11

Other funds holding MRK

Gantzert Investment Company's MRK Position: Q3 2020 in Review

Gantzert Investment Company increased its Merck (MRK) stake by 6.1% in Q3 2020, buying an estimated $202K and bringing the position to 45,001 shares worth $3.56M. The position accounts for 3.22% of the portfolio, ranked #11.

Gantzert Investment Company first reported a position in MRK in Q4 2018 and has held it in 8 quarters since. 2,559 funds tracked by Wall St. Rank hold MRK as of Q3 2020.

  • Gantzert Investment Company held 45,001 shares of Merck worth $3.56M as of Q3 2020.
  • Gantzert Investment Company bought 2,583 Merck shares in Q3 2020, an estimated $202K.
  • Merck made up 3.22% of Gantzert Investment Company's portfolio in Q3 2020, its #11 holding.
  • Gantzert Investment Company first reported a position in Merck in Q4 2018 and has held it in 8 quarters since.
  • 2,559 funds tracked by Wall St. Rank held Merck as of Q3 2020.

Based on Gantzert Investment Company's 13F filing for Q3 2020, filed 7 Oct 2020.